| | |
RIZ1 immunoreactivity (Median = 8.0)
|
|---|
|
Features
|
N(N = 51, %)
|
<Median
|
≥Median
|
P-values
|
|---|
|
Gender
| | | |
0.097
|
|
Male
|
32(62.7)
|
19
|
13
| |
|
Female
|
19(37.3)
|
6
|
13
| |
|
Age
| | | |
0.027*
|
|
< 50 years
|
29(56.9)
|
12
|
17
| |
|
≥ 50 years
|
22(43.1)
|
13
|
9
| |
|
Tumor diameter
| | | |
0.324
|
|
< 6 cm
|
32(62.7)
|
14
|
18
| |
|
≥ 6 cm
|
19(37.3)
|
11
|
8
| |
|
Extent of resection
| | | |
0.436
|
|
Gross-total
|
39(76.5)
|
20
|
19
| |
|
Sub-total
|
12(23.5)
|
5
|
7
| |
|
Pathological grade
| | | |
0.000*
|
|
Low grade
|
12(23.5)
|
1
|
11
| |
|
High grade
|
39(76.5)
|
24
|
15
| |
|
Ki-67 immunoreactivity
| | |
|
< Median
|
24(47.1)
| |
|
≥ Median
|
27(52.9)
| |
- * P < 0.05 was considered statistically significant
- Table 1: Clinicopathological evaluation suggested that RIZ1 expression was associated with tumor grade (p = 0.000) and patient age (P = 0.027)
